請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37465
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝松蒼(Sung-Tsang Hsieh) | |
dc.contributor.author | Hao Chiang | en |
dc.contributor.author | 姜昊 | zh_TW |
dc.date.accessioned | 2021-06-13T15:29:06Z | - |
dc.date.available | 2008-08-13 | |
dc.date.copyright | 2008-08-13 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-17 | |
dc.identifier.citation | Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-244.
Baumann TK, Simone DA, Shain CN, LaMotte RH. (1991) Neurogenic hyperalgesia: the search for the primary cutaneous merent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol 66:212-227. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54-56. Buck SH, Miller MS, Burks TF. (1982) Depletion of primary afferent substance P by capsaicin and dihydrocapsaicin without altered thermal sensitivity in rats. Brain Res 233:216-220. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI. (1998) Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392:390-394. Caterina MJ, Julius D. (2001) The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 24:487–517. Caterina MJ, Lefßer A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. (2000) Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor. Science 288:306-313. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816-24. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63. Chiang HY, Chen CT, Chien HF, Hsieh ST. (2005) Skin denervation, neuropathology, and neuropathic pain in a laser-induced focal neuropathy. Neurobiol Dis 18:40-53. Chien HF, Tseng TJ, Lin WM, Yang CC, Chang YC, Chen RC, Hsieh ST. (2001) Quantitative pathology of cutaneous nerve terminal degeneration in the human skin. Acta Neuropathol 102:455–461. Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD, Albert D, Renold F. (1991) Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 13:383-395. Donnerer J, Liebmann I, Schicho R. (2005) Differential Regulation of 3-Beta- Hydroxysteroid Dehydrogenase and Vanilloid Receptor TRPV1 mRNA in Sensory Neurons by Capsaicin and NGF. Pharmacol 73:97–101 Donnerer J. (2002) Regeneration of primary sensory neurons. Pharmacol 67:169-181. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109:132-142. Fitzgerald M, Woolf CJ. (1982) The time course and specificity of the changes in the behavioral and dorsal horn cell responses to noxious stimuli following peripheral nerve capsaicin treatment in the rat. Neurosci 7:2051-2056. Gamse R. (1982) Capsaicin and nociception in the rat and mouse. Possible role of substance P. Naunyn Schmiedebergs Arch Pharmacol 320:205-216. Gamse R, Lackner D, Gamse G, Leeman SE. (1981) Effect of capsaicin pretreatment on capsaicin-evoked release of immunoreactive somatostatin and substance P from primary sensory neurons. Naunyn Schmiedebergs Arch Pharmacol 316:38-41. Gilchrist HD, Allard BL, Simone DA. (1996) Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats. Pain 67:179-188. Goswami C, Dreger M, Otto H, Schwappach B, Hucho F. (2006) Rapid disassembly of dynamic microtubules upon activation of the capsaicin receptor TRPV1. J Neurochem 96:254-266. Guo A, Vulchanova L, Wang J, Li X, Elde R. (1999) Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11:946-958. Harti G, Sharkey KA, Pierau FK. (1989) Effects of capsaicin in rat and pigeon on peripheral nerves containing substance P and calcitonin gene-related peptide. Cell Tissue Res 256:465-474. Hilliges M, Wang L, Johansson O. (1995) Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J Invest Dermaltol 104: 134-137. Hiura A, Ishizuka H. (1989) Changes in features of degenerating primary sensory neurons with time after capsaicin treatment. Acta Neuropathol 78:35-46. Hiura A, Sakamoto Y. (1987) Effect of capsaicin on neurites of cultured dorsal root ganglia and isolated neurons of chick embryos. Neurosci Lett 73:237-241. Hökfelt T, Kellerth JO, Nilsson G, Pernow B. (1975) Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res 100:235-252. Hsieh ST. (2007) Toxic neuropathies. In: Mager T, Pillmann A (eds) Encyclopedia of Pain, Springer-Verlag Berlin Heidelberg, New York, pp 2493-2498. Hsieh ST, Chiang HY, Lin WM. (2000) Pathology of nerve terminal degeneration in the skin. J Neuropathol Exp Neurol 59:297-307 Hsieh YL, Chiang H, Tseng TJ, Hsieh ST. (2008) Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy. J Neuropathol Exp Neurol 67(2):93-104. Hwang SJ, Oh JM, Valtschanoff JG. (2005) Expression of the vanilloid receptor TRPV1 in rat dorsal root ganglion neurons supports different roles of the receptor in visceral and cutaneous afferents. Brain Res 1047:261 – 266. Jakab G, Szallasi A, Agoston DV. (1994) The calcitonin gene-related peptide (CGRP) phenotype is expressed early and up-regulated by resiniferatoxin (RTX) in mouse sensory neurons. Develop Brain Res 80:290-294. Jancso G, Kiraly E. (1977) Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature 270:741-743. Jancsó N, Jancsó-Gábor A, Szolcsányi J. (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 31:138-151. Jessell TM, Iversen LL, CuelloAC. (1978) Capsaicin-induced depletion of substance P from sensory neurons. Brain Res 152:183-188. Jordt SE, Julius D. (2002) Molecular basis for species-specific sensitivity to “hot” chili peppers. Cell 108:421–430. Jortner BS. (2000) Mechanisms of Toxic Injury in the Peripheral Nervous System: Neuropathologic Considerations. Toxicol Pathol 28:54-69. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, Kim D, Oh U. (1999) Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19:529–538. Kawakami T, Hikawa N, Kusakabe T, Kano M, Bandou Y, Gotoh H, Takenaka T. (1993) Mechanism of inhibitory action of capsaicin on particulate axoplasmic transport in sensory neurons in culture. J Neurobiol 24:545-551. Kawamura M., Kuraishi Y., Minami M. and Satoh M. (1989) Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal and mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res 497:199-203. Kenins P. (1982) Responses of single nerve fibres to capsaicin applied to the skin. Neurosci Lett 29:83-88. Kennedy WR, Wendelschafer-Crabb G. (1993) The innervation of human epidermis. J Neurobio Sci 115:184-190. Ko MW, Chen WP, Hsieh ST. (2002) Neuropathology of Skin Denervation in Acrylamide-Induced Neuropathy. Neurobiol Dis 11:155–165. Lauria G, Lombardi R. (2008) Skin biopsy: a new tool for diagnosing peripheral neuropathy. BMJ 334:1159-1162. Lin YW, Tseng TJ, Lin WM, Hsieh ST. (2001) Cutaneous Nerve Terminal Degeneration in Painful Mononeuropathy. Exp Neurol 170:290-296. Lin WM, Hsieh ST, Huang IT, Griffin JW, Chen WP. (1997) Ultrastructural localization and regulation of protein gene product 9.5. Neuroreport 8:2999-3004. Manni L, Lundeberg T, Tirassa P, Aloe L. (2000) Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit. Br J Pharmacol 129:744-750. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR, Griffin JW, McArthur JC. (1995) Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurol 45:1848-1855. McCarthy GM, McCarty DJ. (1992) Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 19:604-607. Molander C, Ygge J, Dalsgaard. (1987) Substance P-, somatostatin- and calcitonin gene-related peptide-like immunoreactivity and fluoride resistant acid phosphatase-activity in relation to retrogradely labeled cutaneous, muscular and visceral primary sensory neurons in the rat. Neurosci Lett 74:37-42 Nagy JI, van der Kooy D.(1983) Effects of neonatal capsaicin treatment on nociceptive thresholds in the rat. J Neurosci 3:1145-1150. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. (1999) Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 81:135-145. Pan HL, Khan GM, Alloway KD, Chen SR. (2003) Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J Neurosci 23:2911-2919. Petruska JC, Napaporn J, Johnson RD, Gu JG, Cooper BY. (2000) Subclassified Acutely Dissociated Cells of Rat DRG: Histochemistry and Patterns of Capsaicin-, Proton-, and ATP-Activated Currents. J Neurophysiol 84:2365-2379. Petsche U, Fleischer E, Lembeck F, Handwerker HO. (1983) The effect of capsaicin application to a peripheral nerve on impulse conduction in functionally identified afferent nerve fibres. Brain Res 265:233-240. Piercey MF, Moon MW, Blinn JR, Dobry-Schreur PJ. (1986) Analgesic activities of spinal cord substance P antagonists implicate substance P as a neurotransmitter of pain sensation. Brain Res 385:74-85. Post C, Freedman J, Paulsson I, Hökfelt T. (1987) Antinociceptive effects in mice after intrathecal injection of a substance P receptor antagonist, Spantide: lack of 'neurotoxic' action. Regul Pept 18:243-252. Price TJ, Flores CM. (2007) Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. J Pain 8:263-272. Rosenfield MG, Mermond JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM. (1983) Prduction of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129-135. Saade NE, Massaad CA, Ochoa-Chaar CI, Jabbur SJ, Safieh-Garabedian B, Atweh SF. (2002) Upregulation of proinflammatory cytokines and nerve growth factor by intraplantar injection of capsaicin in rats. J Physiol 545:241–253. Scheffler NM, Sheitel PL, Lipton MN. (1991) Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Podiatr Med Assoc 81:288-293. Schicho R, Donnerer J. (1999) Nerve growth factor stimulates synthesis of calcitonin gene-related peptide in dorsal root ganglion cells during sensory regeneration in capsaicin-treated rats. Neurosci Res 35:183–187. Scott LJ, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford T, McArthur JC, Tournay A, Schiffmann R. (1999) Quantitative analysis of epidermal innervation in Fabry disease. Neurol 52:1249-1254. Shu X, Mendell LM. (2001) Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J Neurophysiol 86:2931-2938. Simone DA, Nolano M, Johnson T, Wendelschafer-Crabb G, Kennedy WR. (1998) Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 18:8947-8959. Simone DA, Ochoa J. (1991) Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 47:285-294. Simpson DM, Brown S, Tobias J, NGX-4010 C107 study group. (2008) Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurol 70:2305-2313. Sluka KA. (1997) Activation of the cAMP transduction cascade contributes to the mechanical hyperalgesia and allodynia induced by intradermal injection of capsaicin. Br J Pharmacol 122:1165-1173. Sommer C, Lauria G. (2007) Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 6:632–642. Streit WJ, Schulte BA, Balentine JD, Spicer SS. (1986) Evidence for glycoconjugate in nociceptive primary sensory neurons and its origin from the Golgi complex. Brain Res 377:1-17. Szolcsanyi J, Anton F, Reeh PW, Handwerker HO. (1988) Selective excitation by capsaicin of mechano-heat sensitive nociceptors in rat skin. Brain Res 446:262-268. Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J. (1983) PGP9.5-a new marker for bertebrate neurons and neuroendocrine cells. Brain Res 278:224-228. Thomson RM, Parry GJ. (2006) Neuropathies associated with excessive exposure to lead. Muscle Nerve 33:732–741. Thresh LT. (1846) Isolation of capsaicin. Pharm.J. 6:941. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543. Tseng TJ, Chen CC, Hsieh YL, Hsieh ST. (2007) Effects of decompression on neuropathic pain behaviors and skin reinnervation in chronic constriction injury. Exp Neurol 204:574-582. Verdu E, Vilches JJ, Rodriguez FJ, Ceballos D, Valero A, Navarro X. (1999) Muscle Nerve 22: 329–340. Wiesenfeld-Hallin Z, Hökfelt T, Lundberg JM, Forssmann WG, Reinecke M, Tschopp FA, Fischer JA. (1984) Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett 52:199-204. Wilkinson KD, Lee K, Deshpande S, Duerksen-Hughes P, BossJM, Pohl J. (1989) The neuron-specific protein PGP9.5 is a ubiquitin carbostl-terminal hydrolase. Nature 246:670-671. Wilson POG, Barber PC, Hamid QA, Power BF, Dhillon AP, Rode J, Day INM, Thompson RJ, Polak JM. (1988) Br J Exp Pathol 69: 91-104. Winter J, Bevan S, Campbell EA. (1995) Capsaicin and pain mechanisms. Br J Anaesth 75:157-168. Zara G, Ermani M, Rondinone R, Arienti S, Doria A. (2008) Thalidomide and sensory neurotoxicity: A neurophysiological study. J. Neurol. Neurosurg Psychiatry [Epub ahead of print] Zhang J, Huang W, Tuckett RP. (2002) C-fiber modulation of the rat type I slowly adapting mechanoreceptor. Neurosci 115:797-804. Zimmer A, Zimmer AM, Baffi J, Usdin T, Reynolds K, Konig M, Palkovits M, Mezey E. (1998) Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci 95:2630-2635. Zwick M, Davis BM, Woodbury CJ, Burkett JN, Koerber R, Simpson JF, Albers KM. (2002) Glial Cell Line-Derived Neurotrophic Factor is a Survival Factor for Isolectin B4-Positive, but not Vanilloid Receptor 1-Positive, Neurons in the Mouse. J Neurosci 22:4057-4065. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37465 | - |
dc.description.abstract | 神經毒素造成的神經病變(toxic neuropathy)是周邊神經病變起因之一,而大多數神經毒素會同時影響大直徑及小直徑周邊神經,不易觀察小直徑感覺神經受到損傷時的變化。辣椒素(capsaicin),是辣椒中引起辛辣感的主要成分,接觸辣椒素短期內會造成小直徑感覺神經元興奮,個體對外界刺激則產生過度敏感的症狀。辣椒素重複施用,則造成個體對熱刺激的敏感性降低,因而辣椒素常在臨床上被用於減輕神經性疼痛患者的痛楚,但是辣椒素引起敏感性降低的機制仍未有定論。此外重複使用辣椒素,是否影響個體對機械性刺激的反應,目前無一致結論。本實驗即試圖以周邊重複施用辣椒素建立小直徑周邊神經病變模式,並了解辣椒素對於個體行為、感覺神經纖維表型的表現產生何種影響。
使用成熟ICR公鼠,於單側腳掌連續7日皮下施打10 μl 1% 辣椒素,對側施打等量對照組溶液,在施打第7日起,每周觀察小鼠對熱刺激、機械性刺激反應,分別於第7日及第42日犧牲小鼠,以神經標的抗體protein gene product 9.5 (PGP9.5)、calcitonin gene-related peptide (CGRP)、substance P (SP)進行免疫組織化學染色及電子顯微鏡觀察。 研究結果發現,重複辣椒素施打側的腳掌表現PGP9.5的表皮神經密度相較於對側下降31%,表現神經胜肽CGRP、SP的表皮神經密度分別下降60%以及97%。伴隨著表皮神經密度下降,施打辣椒素側的腳掌對於熱刺激以及機械性刺激均出現敏感性降低的現象。使用電子顯微鏡觀察辣椒素對內側蹠神經(medial plantar nerve)中無髓鞘軸突(ummyelinated axons)構造的變化,許旺氏細胞包含的無髓鞘軸突數目略為下降,軸突出現瓦勒式退化(Wallerian degeneration)特徵的比例較施打對照組溶液側顯著上升。 為了解停止施打辣椒素是否造成功能及神經末梢表型的回復,觀察小鼠停止施打藥物後的行為變化。施打辣椒素第42日,該側腳掌對熱刺激及機械性刺激的反應回復正常。以免疫組織化學染色觀察表皮PGP9.5、CGRP、SP神經纖維的表現情形,施打辣椒素第42日表現PGP9.5與CGRP的表皮神經密度與對側相比無顯著差異,但表現SP的表皮神經密度仍顯著低於對側腳掌,下降78%。 由實驗結果得知,周邊重複辣椒素施打能造成小直徑神經病變,使得個體對外界刺激敏感性降低的功能退減以及表皮神經去支配,周邊神經退化則是造成神經病變的原因之一。此一神經病變可經由停止施打辣椒素逐漸回復個體功能,但辣椒素對於不同表型的表皮神經再支配能力影響不一致。 | zh_TW |
dc.description.abstract | Environmental chemical pollutants and certain medication for chemotherapy are the inducers of toxic neuropathy, which affect the structure and functions of peripheral nerves. Most neurotoxins affect both large and small-diameter neurons, rendering confusion when trying to elucidate the specific effects on different types of neurons. Capsaicin (8-methyl-N-vanillyl-6-noneamide), the main ingredient in hot chili peppers, evoked the pungent sensation on subjects. Meanwhile, it could be applied topically to alleviate pain in patients with neuropathic pain. In this study, we asked whether repeated local injection of capsaicin could serve as a model of small-fiber neuropathy and how behavioral changes developed.
10 μl Capsaicin (1%) was injected daily into one side of the hindpaw of mice for 7 days; the other side was injected with vehicle solution. Using immunuhistochemistry, pan-neuronal marker protein gene product 9.5 (PGP9.5) (+) epidermal nerve density was reduced by 31%, peptidergic neuron marker calcitonin gene-related peptide (CGRP) (+) nerve density by 60%, and substance P (SP) (+) nerve density by 97% after capsaicin treatment on post-injection day 7 (PID7). Accompanying with denervation of epidermis, animals with capsaicin treatment exhibited marked reduction of sensitivity to thermal and mechanical stimuli on PID7 compared with the contralateral side. Unmyelinated axons of medial plantar nerve showed signs of Wallerian-like degeneration under capsaicin treatment. To assess whether capsaicin-induced neuropathy could be reversed, capsaicin injection ceased at PID7. Animals were kept alive and their behaviors were evaluated weekly until PID42. On PID42, both mechanical and thermal responses returned to normal. However, there was difference in the pattern of skin reinnervation among epidermal nerves of different phenotypes. Epidermal nerve density of SP (+) nerve fibers was reduced by 78%, whereas PGP9.5 (+) and CGRP (+) nerve fibers nearly replenished on PID42. These findings provided a model of capsaicin-induced neuropathy and indicated different vulnerability to capsaicin among different types of epidermal nerves. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T15:29:06Z (GMT). No. of bitstreams: 1 ntu-97-R95446003-1.pdf: 960104 bytes, checksum: ecca876c5e529f2e207c1dfac577b9ca (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 口試委員會審定書………………………………………………………i
誌謝………………………………………………………………………ii 中文摘要………………………………………………………………iii 英文摘要…………………………………………………………………v 目錄………………………………………………………………………1 圖目錄……………………………………………………………………2 表目錄……………………………………………………………………3 引言………………………………………………………………………4 實驗材料與方法…………………………………………………………9 結果………………………………………………………………………13 討論………………………………………………………………………18 參考文獻…………………………………………………………………23 圖表與說明………………………………………………………………32 | |
dc.language.iso | zh-TW | |
dc.title | 辣椒素(capsaicin)造成之周邊神經病變:小鼠後腳掌重複施打辣椒素引起之表皮神經消失及功能性變化 | zh_TW |
dc.title | Capsaicin-induced neuropathy: loss of cutaneous nerves and its functional consequences after multiple injections of capsaicin into the hindpaw of mice | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 閔明源(Ming-Yuan Min),陳志成(Chih-Cheng Chen) | |
dc.subject.keyword | 辣椒素,神經去支配,表皮神經退化,神經再支配,小直徑周邊神經病變,物質P, | zh_TW |
dc.subject.keyword | calcitonin gene-related peptide,capsaicin,denervation,nerve degeneration,reinnervation,small-fiber neuropathy,substance P, | en |
dc.relation.page | 62 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-17 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 解剖學暨生物細胞學研究所 | zh_TW |
顯示於系所單位: | 解剖學暨細胞生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 937.6 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。